title: Clinical significance of the K/DOQI bone guidelines in Japan.
authors.forename: Keitaro
authors.initials: K
authors.lastname: Yokoyama
authors.forename: Naohiko
authors.initials: N
authors.lastname: Katoh
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Kubo
authors.forename: Seizo
authors.initials: S
authors.lastname: Murai
authors.forename: Noritugu
authors.initials: N
authors.lastname: Imamura
authors.forename: Ryo
authors.initials: R
authors.lastname: Shoji
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Shigematsu
authors.forename: Masaaki
authors.initials: M
authors.lastname: Nakayama
authors.forename: Shinji
authors.initials: S
authors.lastname: Takasu
authors.forename: Takashi
authors.initials: T
authors.lastname: Kono
authors.forename: Toyohiko
authors.initials: T
authors.lastname: Yoshida
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Hosoya
mesh_terms: D001800:Blood Specimen Collection; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000209:etiology; D007564:Japan; D007674:Kidney Diseases / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D017410:Practice Guidelines as Topic; D012016:Reference Values; D013997:Time Factors; D014481:United States; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D010281:Parathyroid Hormone; D014807:Vitamin D; D010758:Phosphorus